ICAM1 and non-small cell lung carcinoma: IHC of paired samples from NSCLC patients furtherly verified that LKB1 mutant patients displayed lower ICAM1 expression and fewer CD8+ T cells infiltration (Fig. 3h, Supplementary Fig. 12A, B).